top of page
For most cost-effective consulting services:
Click here
Home
All News
Pharma
APAC
APAC - Drug Approvals
Brazil
Canada Pharma
China Pharma
Europe Pharma
India Pharma
Japan Pharma
North America
US FDA Approvals
Therapy News
Immunology
Neurology
Oncology
Kidney Diseases
Cardiovascular
Infections_Vaccines
Metabolic Diseases
Women Health
Healthcare News
US Healthcare News
US Payer News
Europe Healthcare News
Germany Healthcare
Italy
United Kingdom Healthcare
APAC - Healthcare News
Brazil Healthcare
Healthcare Policies
Conferences
About
All Posts
Healthcare Systems
News
Conferences
Know your disease
COVID
Japan drug approvals
USA Pharma News | Healthcare News
Europe Pharma News
Japan drug approvals
Australia Pharma & Healthcare News
Canada Pharma and Healthcare News
Asia | Pharma | Healthcare News
Indication News
Latam
US FDA News
CMS News
India Drug Healthcare
China Drug Approvals
Europe Healthcare News
APAC Drug approvals
US_PayerNews
Australia TGA Approvals
Biosimilars
Radioligand therapy
Chikungunya News
NICE recommendations
G-BA Assessment Outcomes
HAS Assessment Outcomes
Neurology
Immunology
Search
EU Approves Datroway as 1L Monotherapy in PD‑1/PD‑L1–Ineligible Metastatic TNBC After TROPION‑Breast02 Survival Gain
Badari Andukuri
Aug 3
European Commission Authorizes RINVOQ for Severe Alopecia Areata
Badari Andukuri
Jul 30
European Commission Grants Approval for Oral Semaglutide in Weight Management
Badari Andukuri
Jul 16
Enhertu Gains EU Tumour‑Agnostic Approval For HER2‑Positive Metastatic Solid Tumours | iPharmaCenter
Badari Andukuri
Jun 29
Hospital and Drug Costs Outpace Contributions in Germany, Raising Pressure on Pharma Pricing
Badari Andukuri
Jun 27
June 2026: CHMP Signals New Options in CLL, TNBC and Multiple Myeloma
Badari Andukuri
Jun 27
Sanofi’s Cenrifki Wins EU Approval for Non-Relapsing Secondary Progressive MS | iPharmaCenter
Badari Andukuri
Jun 23
EU Launches Era of Centralized HTA with First Joint Clinical Assessment of Ojemda | iPharmaCenter
Badari Andukuri
Jun 11
Spain Explores Italy’s HTA Model to Advance EU HTA Regulation Implementation | iPharmaCenter
Badari Andukuri
May 27
Germany Advances Pharmacy Reform with ApoVWG Law to Strengthen Rural Access and Healthcare Services
Badari Andukuri
May 25
Europe’s Pharmaceutical Strategy in a Changing Global Order: Germany and France Push for Resilience and Competitiveness | iPharmaCenter
Badari Andukuri
May 22
New Hope for GVHD Patients as Rezurock Wins EU Approval | iPharmaCenter
Badari Andukuri
Apr 2
Amgen’s Uplizna wins European Commission approval for generalized myasthenia gravis | iPharmaCenter
ipharmaservices
Feb 17
GSK’s ultra‑long‑acting IL‑5 biologic Exdensur wins EU approval for severe asthma and CRSwNP | iPharmaCenter
ipharmaservices
Feb 17
GSK’s RSV Vaccine, Arexvy is now approved for all adults in Europe | iPharmaCenter
ipharmaservices
Feb 1
EMA Begins Review of Trastuzumab Deruxtecan Plus Pertuzumab as First-Line Therapy for HER2 Positive Metastatic Breast Cancer | iPharmaCenter
Badari Andukuri
Jan 20
Germany’s Federal Ministry of Health (BMG) initiated two research funding projects to strengthen women's health | iPharmaCenter
Badari Andukuri
Jan 17
European Commission grants approval to Sanofi's Wayrilz for refractory immune thrombocytopenia | iPharmaCenter
ipharmaservices
Dec 29, 2025
Johnson & Johnson Secures European Commission Approval for IMAAVY (Nipocalimab) to Treat Generalised Myasthenia Gravis
Badari Andukuri
Dec 5, 2025
US–Swiss Tariff Cap Impact on Pharma: How the New US–Swiss Tariff Cap Shapes Pharma and Health Security
ipharmaservices
Dec 2, 2025
bottom of page
